172 related articles for article (PubMed ID: 8849243)
1. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
Brown BA; Wallace RJ; Onyi G
Antimicrob Agents Chemother; 1996 Apr; 40(4):874-8. PubMed ID: 8849243
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of two new glycylcyclines, N,N-dimethylglycylamido derivatives of minocycline and 6-demethyl-6-deoxytetracycline, against 339 strains of anaerobic bacteria.
Wexler HM; Molitoris E; Finegold SM
Antimicrob Agents Chemother; 1994 Oct; 38(10):2513-5. PubMed ID: 7840601
[TBL] [Abstract][Full Text] [Related]
3. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
[TBL] [Abstract][Full Text] [Related]
4. Susceptibilities of Neisseria gonorrhoeae to the glycylcyclines.
Whittington WL; Roberts MC; Hale J; Holmes KK
Antimicrob Agents Chemother; 1995 Aug; 39(8):1864-5. PubMed ID: 7486935
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
[TBL] [Abstract][Full Text] [Related]
6. A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.
Someya Y; Yamaguchi A; Sawai T
Antimicrob Agents Chemother; 1995 Jan; 39(1):247-9. PubMed ID: 7695316
[TBL] [Abstract][Full Text] [Related]
7. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
Goldstein FW; Kitzis MD; Acar JF
Antimicrob Agents Chemother; 1994 Sep; 38(9):2218-20. PubMed ID: 7811053
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).
Petersen PJ; Jacobus NV; Weiss WJ; Sum PE; Testa RT
Antimicrob Agents Chemother; 1999 Apr; 43(4):738-44. PubMed ID: 10103174
[TBL] [Abstract][Full Text] [Related]
9. Two investigational glycylcyclines, DMG-DMDOT and DMG-MINO. Antimicrobial activity studies against gram-positive species.
Johnson DM; Jones RN
Diagn Microbiol Infect Dis; 1996 Jan; 24(1):53-7. PubMed ID: 8988765
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of two glycylcyclines against gram-positive bacteria.
Eliopoulos GM; Wennersten CB; Cole G; Moellering RC
Antimicrob Agents Chemother; 1994 Mar; 38(3):534-41. PubMed ID: 8203851
[TBL] [Abstract][Full Text] [Related]
12.
Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the interdomain loop region of the tetA(A) tetracycline resistance gene increase efflux of minocycline and glycylcyclines.
Tuckman M; Petersen PJ; Projan SJ
Microb Drug Resist; 2000; 6(4):277-82. PubMed ID: 11272255
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1993 Oct; 12(10):784-6. PubMed ID: 7802861
[TBL] [Abstract][Full Text] [Related]
15. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of two glycylcyclines.
Wise R; Andrews JM
Antimicrob Agents Chemother; 1994 May; 38(5):1096-102. PubMed ID: 8067744
[TBL] [Abstract][Full Text] [Related]
17.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33288634
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
Govendir M; Norris JM; Hansen T; Wigney DI; Muscatello G; Trott DJ; Malik R
Vet Microbiol; 2011 Dec; 153(3-4):240-5. PubMed ID: 21726965
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines.
Weiss WJ; Jacobus NV; Petersen PJ; Testa RT
J Antimicrob Chemother; 1995 Jul; 36(1):225-30. PubMed ID: 8537270
[TBL] [Abstract][Full Text] [Related]
20. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection.
Bergeron J; Ammirati M; Danley D; James L; Norcia M; Retsema J; Strick CA; Su WG; Sutcliffe J; Wondrack L
Antimicrob Agents Chemother; 1996 Sep; 40(9):2226-8. PubMed ID: 8878615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
